Pharma Equity Group A/S (CPH: PEG)
Denmark flag Denmark · Delayed Price · Currency is DKK
0.213
-0.023 (-9.75%)
Oct 2, 2024, 4:51 PM CET

Pharma Equity Group Statistics

Total Valuation

Pharma Equity Group has a market cap or net worth of DKK 214.82 million. The enterprise value is 257.84 million.

Market Cap 214.82M
Enterprise Value 257.84M

Important Dates

The next estimated earnings date is Friday, November 15, 2024.

Earnings Date Nov 15, 2024
Ex-Dividend Date n/a

Share Statistics

Pharma Equity Group has 1.02 billion shares outstanding. The number of shares has increased by 12.08% in one year.

Shares Outstanding 1.02B
Shares Change (YoY) +12.08%
Shares Change (QoQ) +0.25%
Owned by Insiders (%) 4.89%
Owned by Institutions (%) 0.18%
Float 690.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 8.29
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -8.37
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 1.69.

Current Ratio 1.92
Quick Ratio 0.10
Debt / Equity 1.69
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.89

Financial Efficiency

Return on equity (ROE) is -75.32% and return on invested capital (ROIC) is -24.77%.

Return on Equity (ROE) -75.32%
Return on Assets (ROA) -22.47%
Return on Capital (ROIC) -24.77%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.38% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -45.38%
50-Day Moving Average 0.26
200-Day Moving Average 0.30
Relative Strength Index (RSI) 29.21
Average Volume (20 Days) 645,017

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -29.16M
Pretax Income -32.86M
Net Income -30.81M
EBITDA -28.92M
EBIT -29.16M
Earnings Per Share (EPS) -0.03
Full Income Statement

Balance Sheet

The company has 863,000 in cash and 43.88 million in debt, giving a net cash position of -43.02 million or -0.04 per share.

Cash & Cash Equivalents 863,000
Total Debt 43.88M
Net Cash -43.02M
Net Cash Per Share -0.04
Equity (Book Value) 25.90M
Book Value Per Share 0.03
Working Capital 29.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -18.55M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Pharma Equity Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.08%
Shareholder Yield -12.08%
Earnings Yield -13.42%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a